arrow
C

C.J. Duncan

newcastle university - uk
H指数:65
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults
2024-06-187
OAAI
Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis

截断NFKB1变体会导致NLRP3炎性体激活和I型干扰素信号传导相结合,并易患坏死性筋膜炎

2024-04-011
OAAI
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults

基于mRNA的RSV PreF疫苗在老年人中的功效和安全性

2023-12-1491
OA
CD4+and CD8+T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study

CD4和CD8 T细胞和抗体与预防Delta疫苗突破性感染相关: PITCH研究中的巢式病例对照研究

MBIO
IF4.7
2023-10-314
OAAI
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial
2023-09-0120
OAAI
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history

疫苗接种后的Omicron感染可增强依赖于感染史的广泛免疫反应

2023-08-2118
OAAI
Human inherited complete STAT2 deficiency underlies inflammatory viral diseases
2023-06-1511
OAAI
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study-A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

Com-COV2研究中异源COVID疫苗接种计划中免疫反应的持久性-一项纳入mRNA,病毒载体和蛋白质佐剂疫苗的单盲,随机试验

2023-06-017
OAAI
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
2022-09-2328
OAAI
Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults

灭活全病毒佐剂新型冠状病毒肺炎疫苗VLA2001的安全性和免疫原性: 健康成人的随机,剂量递增,双盲1/2期临床试验

2022-09-0116
OAAI
Clinical features and management of human monkeypox: a retrospective observational study in the UK
2022-08-01819
OAAI
Conjunctival epithelial cells resist productive SARS-CoV-2 infection
2022-07-018
OAAI